{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:03:44Z","timestamp":1777032224653,"version":"3.51.4"},"reference-count":47,"publisher":"Georg Thieme Verlag KG","issue":"04","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bronchiectasis is a heterogenous disease with multiple etiologies and associated comorbidities. As bronchiectasis is a complex disease, it is unsound to think of it as a single disease particularly when the differing etiologies are likely to be driving bronchiectasis through initial divergent molecular pathways, known as endotypes, that phenotypically present as the same disease due to protracted airway inflammation, but revealing potential differing underlying mechanisms that may have disparity of drug responses. Improved understanding of the cellular immune, inflammatory, and microbiological milieu associated with clinical and radiological features of bronchiectasis has resulted in the recognition of important endotypes and phenotypes that will allow for personalized treatments to improve quality of life and outcomes of patients with bronchiectasis. Here we discuss clinical and radiological phenotypes, as well as emerging molecular endotypes that are possible treatable traits in bronchiectasis.<\/jats:p>","DOI":"10.1055\/s-0041-1730894","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T22:34:05Z","timestamp":1626302045000},"page":"549-555","source":"Crossref","is-referenced-by-count":12,"title":["Clinical and Radiological Phenotypes and Endotypes"],"prefix":"10.1055","volume":"42","author":[{"given":"Ricardo J.","family":"Jos\u00e9","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom"},{"name":"Centre for Inflammation and Tissue Repair, University College London, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Loebinger","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom"},{"name":"National Heart and Lung Institute, Imperial College, London, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"issue":"S 10","key":"ref1","doi-asserted-by":"crossref","first-page":"C146","DOI":"10.12968\/hmed.2014.75.Sup10.C146","article-title":"Bronchiectasis","volume":"75","author":"R J Jos\u00e9","year":"2014","journal-title":"Br J Hosp Med"},{"key":"ref2","first-page":"3332","volume-title":"Heterogeneity of treatment response in bronchiectasis clinical trials","author":"O Sibila","year":"2020"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"P A Flume","year":"2018","journal-title":"Lancet"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12931-019-1242-4","article-title":"Primary immunodeficiency-related bronchiectasis in adults: comparison with bronchiectasis of other etiologies in a French reference center","volume":"20","author":"H Goussault","year":"2019","journal-title":"Respir Res"},{"issue":"04","key":"ref5","first-page":"00166","article-title":"De novo bronchiectasis in haematological malignancies: patient characteristics, risk factors and survival","volume":"5","author":"R J Jos\u00e9","year":"2019","journal-title":"ERJ Open Res"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/cei.13068","article-title":"Bronchiectasis and deteriorating lung function in agammaglobulinaemia despite immunoglobulin replacement therapy","volume":"191","author":"A Stubbs","year":"2018","journal-title":"Clin Exp Immunol"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"1801269","DOI":"10.1183\/13993003.01269-2018","article-title":"Treatable traits in bronchiectasis","volume":"52","author":"R Boaventura","year":"2018","journal-title":"Eur Respir J"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1378\/chest.11-1024","article-title":"Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture","volume":"142","author":"P J McShane","year":"2012","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1164\/ajrccm.162.4.9906120","article-title":"An investigation into causative factors in patients with bronchiectasis","volume":"162","author":"M C Pasteur","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.rmed.2013.04.013","article-title":"Phenotyping adults with non-cystic fibrosis bronchiectasis: a prospective observational cohort study","volume":"107","author":"G A Anwar","year":"2013","journal-title":"Respir Med"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MCP.0000000000000569","article-title":"Bronchiectasis phenotypes","volume":"25","author":"P Chang-Macchiu","year":"2019","journal-title":"Curr Opin Pulm Med"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1513\/AnnalsATS.201507-472OC","article-title":"Etiology of non-cystic fibrosis bronchiectasis in adults and its correlation to disease severity","volume":"12","author":"S Lonni","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"06","key":"ref13","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3109\/15412555.2014.922174","article-title":"COPD-related bronchiectasis: independent impact on disease course and outcomes","volume":"11","author":"T Gatheral","year":"2014","journal-title":"COPD"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"e0150532","DOI":"10.1371\/journal.pone.0150532","article-title":"Bronchiectasis as a comorbidity of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"11","author":"Q Du","year":"2016","journal-title":"PLoS One"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.chest.2016.11.024","article-title":"Quantitative CT measures of bronchiectasis in smokers","volume":"151","author":"A A Diaz","year":"2017","journal-title":"Chest"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"109219","DOI":"10.1155\/2013\/109219","article-title":"Prevalence of bronchiectasis in asthma according to oral steroid requirement: influence of immunoglobulin levels","volume":"2013","author":"M Luj\u00e1n","year":"2013","journal-title":"BioMed Res Int"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/S0041-87812001000300001","article-title":"Persistent asthma in adults: comparison of high resolution computed tomography of the lungs after one year of follow-up","volume":"56","author":"A Cukier","year":"2001","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"ref18","first-page":"PA2665","volume-title":"Peripheral blood eosinophilia and clinical phenotype in bronchiectasis","author":"H Abo-Leyah","year":"2018"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.chest.2017.06.042","article-title":"De novo development of bronchiectasis in patients with hematologic malignancy","volume":"152","author":"L W Chen","year":"2017","journal-title":"Chest"},{"issue":"06","key":"ref20","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.chest.2016.12.024","article-title":"Bronchiectasis rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis: a multicenter cohort study","volume":"151","author":"A De Soyza","year":"2017","journal-title":"Chest"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/thx.42.2.155","article-title":"Bronchiectasis with ulcerative colitis and myelopathy","volume":"42","author":"W R Gibb","year":"1987","journal-title":"Thorax"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/thx.53.6.529","article-title":"Bronchiectasis following colectomy for Crohn's disease","volume":"53","author":"T E Eaton","year":"1998","journal-title":"Thorax"},{"issue":"04","key":"ref23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.01899-2015","article-title":"Clinical phenotypes in adult patients with bronchiectasis","volume":"47","author":"S Aliberti","year":"2016","journal-title":"Eur Respir J"},{"issue":"11","key":"ref24","first-page":"1602","article-title":"A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"S Finch","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: a long-term study assessing the factors influencing survival","volume":"34","author":"M R Loebinger","year":"2009","journal-title":"Eur Respir J"},{"issue":"05","key":"ref26","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis","volume":"132","author":"M A Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Chest"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1378\/chest.128.2.739","article-title":"Quality-of-life determinants in patients with clinically stable bronchiectasis","volume":"128","author":"M A Mart\u00ednez-Garc\u00eda","year":"2005","journal-title":"Chest"},{"issue":"11","key":"ref28","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis","volume":"197","author":"J D Chalmers","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.rmed.2016.06.007","article-title":"Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis","volume":"117","author":"R Wilson","year":"2016","journal-title":"Respir Med"},{"issue":"05","key":"ref30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O","article-title":"Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis","volume":"23","author":"B Frederiksen","year":"1997","journal-title":"Pediatr Pulmonol"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ppul.21525","article-title":"Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis","volume":"47","author":"N Mayer-Hamblett","year":"2012","journal-title":"Pediatr Pulmonol"},{"issue":"03","key":"ref32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.rmed.2011.11.018","article-title":"Outcomes of Pseudomonas eradication therapy in patients with non-cystic fibrosis bronchiectasis","volume":"106","author":"L White","year":"2012","journal-title":"Respir Med"},{"issue":"06","key":"ref33","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","article-title":"Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance","volume":"109","author":"M J McDonnell","year":"2015","journal-title":"Respir Med"},{"issue":"12","key":"ref34","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/thx.2005.046631","article-title":"Non-tuberculous mycobacteria in patients with bronchiectasis","volume":"60","author":"M Wickremasinghe","year":"2005","journal-title":"Thorax"},{"issue":"01","key":"ref35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12890-020-01331-3","article-title":"New-onset nontuberculous mycobacterial pulmonary disease in bronchiectasis: tracking the clinical and radiographic changes","volume":"20","author":"N Kwak","year":"2020","journal-title":"BMC Pulm Med"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1378\/chest.101.6.1605","article-title":"Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern: the Lady Windermere syndrome","volume":"101","author":"J M Reich","year":"1992","journal-title":"Chest"},{"issue":"11","key":"ref37","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1016\/j.ijid.2013.03.018","article-title":"Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis","volume":"17","author":"M Mirsaeidi","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"09","key":"ref38","doi-asserted-by":"crossref","first-page":"e0185095","DOI":"10.1371\/journal.pone.0185095","article-title":"Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria","volume":"12","author":"M D Schweitzer","year":"2017","journal-title":"PLoS One"},{"issue":"02","key":"ref39","doi-asserted-by":"crossref","first-page":"1701953","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis","volume":"51","author":"D Ara\u00fajo","year":"2018","journal-title":"Eur Respir J"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"J Altenburg","year":"2013","journal-title":"JAMA"},{"issue":"02","key":"ref41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1183\/09031936.00018414","article-title":"Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review","volume":"44","author":"A M Brodt","year":"2014","journal-title":"Eur Respir J"},{"issue":"01","key":"ref42","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1465-9921-15-44","article-title":"The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis--a randomised controlled trial","volume":"15","author":"A L Lee","year":"2014","journal-title":"Respir Res"},{"key":"ref43","first-page":"PA2671","volume-title":"Explorative analyses of inflammatory pathways and the effect of azithromycin in bronchiectasis patients","author":"Y S Sabogal Pi\u00f1eros","year":"2019"},{"key":"ref44","first-page":"OA473","volume-title":"Endotyping of COPD, bronchiectasis and their overlap syndrome by integrated sputum proteome\/microbiome","author":"J T-J Huang","year":"2019"},{"key":"ref45","first-page":"324","volume-title":"Sputum proteomics identifies distinct endotypes of exacerbations in bronchiectasis","author":"J T-J Huang","year":"2020"},{"key":"ref46","first-page":"PA2170","volume-title":"Inflammatory molecular endotypes in bronchiectasis","author":"A Shoemark","year":"2019"},{"key":"ref47","first-page":"S2213","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","author":"H R Keir","year":"2021","journal-title":"Lancet Respir Med"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1730894.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T01:52:03Z","timestamp":1639792323000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1730894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":47,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2021,7,14]]},"published-print":{"date-parts":[[2021,8]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1730894","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}